Trademark: 97510467
Status Date
Tuesday, March 5, 2024
Filing Date
Tuesday, July 19, 2022
Published for Opposition
Tuesday, January 9, 2024
5 Pharmaceutical preparations namely, monoclonal antibodies, small molecules, nanobodies, small interfering ribonucleic acids (siRNAs), antisense oligonucleotides (ASOs), cell therapies, gene therapies/editors, epigenetic modulators, and protein degraders, namely, small molecule proteolysis-targeting chimera (PROTACs), all of the foregoing for the treatment and prevention of aging and age-related diseases
Mar 5, 2024
Noa E-Mailed - Sou Required From Applicant
Jan 9, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 9, 2024
Published For Opposition
Dec 20, 2023
Notification Of Notice Of Publication E-Mailed
Dec 6, 2023
Approved For Pub - Principal Register
Nov 14, 2023
Teas/Email Correspondence Entered
Nov 13, 2023
Correspondence Received In Law Office
Nov 13, 2023
Teas Response To Office Action Received
Jul 27, 2023
Application Extension Granted/Receipt Provided
Jul 27, 2023
Application Extension To Response Period - Received
May 11, 2023
Notification Of Non-Final Action E-Mailed
May 11, 2023
Non-Final Action E-Mailed
May 11, 2023
Non-Final Action Written
May 3, 2023
Assigned To Examiner
Apr 10, 2023
Teas Change Of Correspondence Received
Apr 10, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 10, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 9, 2022
New Application Office Supplied Data Entered
Jul 22, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
